API
< Back to situations

[ORGANIZATION]

Dr. Reddy’s Laboratories

Featured in 7 tracked stories · first seen

Situations

[QUIET] [HEALTH] [US] [BR] [IN]

Lenacapavir HIV prevention rollout and generic approval

16 clusters · 142 sources · last updated

Latest: FDA approves generic lenacapavir for HIV prevention

Lenacapavir, a long-acting injectable medication for HIV pre-exposure prophylaxis (PrEP), has demonstrated high efficacy in clinical trials, reducing the risk of HIV transmission by 99.9%. The drug, which requires only t

[QUIET] [HEALTH] [BR] [IN]

Anvisa approval of GLP-1 medications in Brazil

2 clusters · 38 sources · last updated

Latest: Anvisa approves five new injectable pens for diabetes and obesity

Brazil’s National Health Surveillance Agency (Anvisa) has approved the registration of five new GLP-1 receptor agonist medication pens for treating diabetes and obesity. These new products include Aribet, Lyrza, and Wylo

Also covered in